A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers
Clinical trial NCT03156738 · COMPLETED
Trial details
- NCT number
- NCT03156738
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2017-12-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.